| abstract |
The present invention relates to the use of the human Herpesvirus 6 U94 molecule or a derivative thereof, or a gene expression vector including and expressing the human Herpesvirus 6 U94 gene, to enhance or induce the expression of the HLA-G molecule by human cells. According to the invention, the U94 molecule or derivative thereof, or the vector, are used in vivo in a patient or in vitro in cell, tissue or organ cultures, to modulate HLA-G expression in order to perform a tolerogenic and anti-inflammatory action. |